Bart Westendorp
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- Ubiquitin and proteasome pathways 7
- DNA Repair Mechanisms 6
- RNA modifications and cancer 5
- Epigenetics and DNA Methylation 4
- Oncology 15
- Cancer-related Molecular Pathways 11
- Co-authors
- Alain de Bruin (21 shared papers)Shusil K. Pandit (3 shared papers)Peter C.J. Tooten (3 shared papers)M.J.M. Toussaint (4 shared papers)Michal Mokrý (2 shared papers)Edwin Cuppen (1 shared paper)Frank C. P. Holstege (1 shared paper)Marian J.A. Groot Koerkamp (1 shared paper)
- Journals
- Oncogene (4 papers)The EMBO Journal (3 papers)EMBO Reports (2 papers)European Journal of Pharmacology (2 papers)European Journal of Heart Failure (2 papers)
- Partner nations
- NetherlandsUnited StatesPakistan
In The Last Decade
Bart Westendorp
37 papers receiving 911 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 152
- Oncology 260
- Cell Biology 150
- Hepatology 60
- Molecular Biology 567
Countries citing papers authored by Bart Westendorp
This map shows the geographic impact of Bart Westendorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Westendorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Westendorp more than expected).
Fields of papers citing papers by Bart Westendorp
This network shows the impact of papers produced by Bart Westendorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Westendorp. The network helps show where Bart Westendorp may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Westendorp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 130 | |
| 2 | 2013 | 126 | |
| 3 | 2012 | 106 | |
| 4 | 2011 | 97 | |
| 5 | 2016 | 54 | |
| 6 | 2019 | 37 | |
| 7 | 2020 | 31 | |
| 8 | 2016 | 27 | |
| 9 | 2018 | 25 | |
| 10 | 2011 | 25 | |
| 11 | 2020 | 23 | |
| 12 | 2023 | 23 | |
| 13 | 2020 | 20 | |
| 14 | 2017 | 19 | |
| 15 | 2013 | 18 | |
| 16 | 2012 | 17 | |
| 17 | 2021 | 15 | |
| 18 | 2022 | 13 | |
| 19 | 2022 | 13 | |
| 20 | 2022 | 11 |
About Bart Westendorp
Bart Westendorp is a scholar working on Molecular Biology, Oncology, Cardiology and Cardiovascular Medicine, Cancer Research and Cell Biology, having authored 41 papers that have together received 917 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (11 papers), Ubiquitin and proteasome pathways (7 papers), DNA Repair Mechanisms (6 papers), RNA modifications and cancer (5 papers), Microtubule and mitosis dynamics (4 papers), Renin-Angiotensin System Studies (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (152 citations), Oncology (260 citations), Cell Biology (150 citations), Hepatology (60 citations) and Molecular Biology (567 citations). Bart Westendorp has collaborated with scholars based in Netherlands, United States and Pakistan. Frequent co-authors include Alain de Bruin, Shusil K. Pandit, Peter C.J. Tooten, M.J.M. Toussaint, Michal Mokrý, Edwin Cuppen, Frank C. P. Holstege, Marian J.A. Groot Koerkamp, Bart Weijts and Walbert J. Bakker. Their work appears in journals such as Oncogene, The EMBO Journal, EMBO Reports, European Journal of Pharmacology and European Journal of Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.